Singapore markets open in 38 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,047.44 +766.61 (+1.32%) CMC Crypto 200
1,273.56 +2.81 (+0.22%)
INCY Sep 2024 57.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:25PM EDT. Market open.
| Previous close | 7.10 |
| Open | 7.10 |
| Bid | 5.50 |
| Ask | 5.90 |
| Strike | 57.50 |
| Expiry date | 2024-09-20 |
| Day's range | 7.10 - 7.10 |
| Contract range | N/A |
| Volume | |
| Open interest | 125 |
Business WireIncyte to Present at Upcoming Investor Conference
WILMINGTON, Del., May 02, 2024--Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 at 8:00 a.m. (PDT) in Las Vegas.
Insider MonkeyIncyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript
Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript April 30, 2024 Incyte Corporation misses on earnings expectations. Reported EPS is $0.746 EPS, expectations were $0.88. INCY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to Incyte First […]
ZacksIncyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Incyte's (INCY) first-quarter 2024 earnings and revenues miss estimates. The company maintains 2024 revenue guidance for its lead drug, Jakafi.
© 2024 Yahoo. All rights reserved.